Viehbacher to lead Sanofi-Aventis
Published: Wed, Sep. 10, 2008 10:39AM
Modified Wed, Sep. 10, 2008 10:39AM
E-Mail
Print
tool name
closeChris Viehbacher, the top ranked executive at GlaxosmithKline's U.S. headquarters in Research Triangle Park, will become chief executive of Sanofi-Aventis.
Effective Dec. 1, Viehbacher will replace Gerard Le Fur, who was on the job for just 18 months at the French drugmaker. Le Fur will continue in an advisory role.
Viehbacher, who was passed over for the top job at GSK last year, announced Monday that he was leaving the British drugmaker effective Dec. 1. He already resigned from the board of directors.
More Business
sabine.vollmer@newsobserver.com or (919) 829-8992.
Get it all with convenient home delivery of The News & Observer.
The News & Observer is pleased to be able to offer its users the opportunity to make comments and hold conversations online. However, the interactive nature of the internet makes it impracticable for our staff to monitor each and every posting.
Since The News & Observer does not control user submitted statements, we cannot promise that readers will not occasionally find offensive or inaccurate comments posted on our website. In addition, we remind anyone interested in making an online comment that responsibility for statements posted lies with the person submitting the comment, not The News and Observer.
If you find a comment offensive, clicking on the exclamation icon will flag the comment for review by the administrators, we are counting on the good judgment of all our readers to help us.
